Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting
保加利亚转移性乳腺癌一线内分泌治疗患者中PIK3CA突变的患病率和预后
期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1966
Gencheva, R; Petrova, M; Kraleva, P; Hadjidekova, S; Radanova, M; Conev, N; Stoyanov, D; Arabadjiev, J; Tazimova, E; Bachurska, S; Eneva, M; Tsvetkova, M; Zhbantov, G; Karanikolova, T; Manov, D; Ivanova, A; Taushanova-Hadjieva, M; Staneva, R; Dimitrova, E; Donev, I